Mp. Schuijt et al., Prostanoids, but not nitric oxide, counterregulate angiotensin II mediatedvasoconstriction in vivo, EUR J PHARM, 428(3), 2001, pp. 331-336
To evaluate the modulating effects of nitric oxide and prostanoids during a
ngiotensin II-mediated vasoconstriction, male Wistar rats (n = 25) were inf
used with increasing doses of angiotensin II following pretreatment with th
e cyclooxygenase inhibitor indomethacin, the nitric oxide-synthase inhibito
r NG-nitro-L-arginine methyl ester (L-NAME) plus sodium nitroprusside to re
store mean arterial blood pressure. or saline. Hemodynamics were studied wi
th the radioactive microsphere method. Indomethacin did not alter systemic
or regional hemodynamics. L-NAME + sodium nitroprusside reduced cardiac out
put, as well as systemic and renal vascular conductance. Angiotensin II inc
reased mean arterial blood pressure and heart rate, and decreased systemic
vascular conductance as well as vascular conductance in gastrointestinal tr
act, kidney, skeletal muscle, skin, mesentery + pancreas, spleen and adrena
l. Indomethacin enhanced the angiotensin II-mediated effects in all vascula
r beds, whereas L-NAME + sodium nitroprusside enhanced its effect in mesent
ery + pancreas only. In conclusion, vasodilator prostanoids, but not nitric
oxide, counterregulate angiotensin II-mediated vasoconstriction in vivo. (
C) 2001 Elsevier Science B.V. All rights reserved.